We are live on ! Find out more
LA

Lee Ainslie Maverick Capital

AUM $11.3B
1-Year Est. Return 76.6%
 

Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.

This Fund
S&P 500
This Quarter Est. Return
+0.99%
1 Year Est. Return
+76.6%
3 Year Est. Return
+266.43%
5 Year Est. Return
+219.63%
10 Year Est. Return
+601.38%
AUM
$8.85B
AUM Growth
-$1.07B
Cap. Flow
-$1.02B
Cap. Flow %
-11.52%
Top 10 Hldgs %
56.72%
Holding
681
New
56
Increased
52
Reduced
179
Closed
373

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 43.56%
2 Technology 17.09%
3 Healthcare 11.19%
4 Communication Services 9.35%
5 Financials 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRBR icon
101
BellRing Brands
BRBR
$1.24B
$163K ﹤0.01%
5,728
-27,967
-83% -$731K
HIMX
102
Himax Technologies
HIMX
$2.35B
$152K ﹤0.01%
9,478
-46,045
-83% -$504K
BKD icon
103
Brookdale Senior Living
BKD
$2.87B
$151K ﹤0.01%
29,304
-126,142
-81% -$787K
DVA icon
104
DaVita
DVA
$11.1B
$148K ﹤0.01%
1,303
-7,185
-85% -$772K
ACLS icon
105
Axcelis
ACLS
$3.81B
$145K ﹤0.01%
+1,944
New +$115K
LPX icon
106
Louisiana-Pacific
LPX
$5.07B
$145K ﹤0.01%
1,850
-22,253
-92% -$1.53M
TNL icon
107
Travel + Leisure Co
TNL
$4.38B
$145K ﹤0.01%
2,617
-17,589
-87% -$941K
AA icon
108
Alcoa
AA
$13.2B
$144K ﹤0.01%
2,423
-2,317
-49% -$116K
SBGI icon
109
Sinclair Inc
SBGI
$1.06B
$143K ﹤0.01%
+5,414
New +$145K
THC icon
110
Tenet Healthcare
THC
$22.4B
$143K ﹤0.01%
1,750
-13,830
-89% -$1.01M
WFG icon
111
West Fraser Timber
WFG
$5.36B
$142K ﹤0.01%
1,490
-13,222
-90% -$1.14M
VALE icon
112
Vale
VALE
$64.4B
$141K ﹤0.01%
10,073
+3,642
+57% +$48.4K
MOH icon
113
Molina Healthcare
MOH
$10.4B
$139K ﹤0.01%
437
-8,679
-95% -$2.58M
PLAN
114
DELISTED
Anaplan, Inc.
PLAN
$139K ﹤0.01%
3,027
-32,742
-92% -$1.81M
ST icon
115
Sensata Technologies
ST
$6.11B
$138K ﹤0.01%
2,232
-16,603
-88% -$967K
CVLT icon
116
Commault Systems
CVLT
$5.48B
$137K ﹤0.01%
1,984
-11,738
-86% -$801K
MD icon
117
Pediatrix Medical
MD
$2.17B
$137K ﹤0.01%
5,051
-30,161
-86% -$807K
CHRD icon
118
Chord Energy
CHRD
$7.87B
$136K ﹤0.01%
+1,079
New +$128K
NWG icon
119
NatWest
NWG
$74.4B
$136K ﹤0.01%
20,645
-155,227
-88% -$1.01M
OI icon
120
O-I Glass
OI
$1.11B
$136K ﹤0.01%
11,320
-60,938
-84% -$772K
ON icon
121
ON Semiconductor
ON
$27.9B
$136K ﹤0.01%
+2,000
New +$113K
ETRN
122
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$136K ﹤0.01%
+13,155
New +$136K
KL
123
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$136K ﹤0.01%
3,237
-25,119
-89% -$1.06M
ALGN icon
124
Align Technology
ALGN
$11.4B
$135K ﹤0.01%
205
-962
-82% -$619K
CACC icon
125
Credit Acceptance
CACC
$6.26B
$135K ﹤0.01%
197
-1,983
-91% -$1.28M

Similar funds

Lee Ainslie's Q4 2021 Portfolio in Review

As of Q4 2021, Lee Ainslie held 681 positions worth $8.85B, down 11% from $9.92B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Lee Ainslie withdrew a net $1.02B in Q4 2021, closing 373 positions and reducing 179 holdings. Its most notable exit was Centene, an estimated $257M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Lee Ainslie opened a new position in Rivian worth $51.8M.

  • Lee Ainslie's largest Q4 2021 buy was Rivian: 500,000 shares worth $51.8M.
  • Lee Ainslie added most to Oak Street Health, Inc. in Q4 2021, an estimated $150M increase.
  • Lee Ainslie's biggest Q4 2021 reduction was Coupang, cutting an estimated $279M.
  • Lee Ainslie fully exited Centene in Q4 2021, selling an estimated $257M.
  • Lee Ainslie's ten largest holdings make up 57% of its $8.85B portfolio in Q4 2021.
  • Lee Ainslie opened 56 new positions and closed 373 in Q4 2021.
  • Lee Ainslie's portfolio value fell 11% quarter-over-quarter to $8.85B.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.